13.21  0.95 (7.75%)		04-08 12:47
Open: 12.88 High: 13.365 Volume: 158,432		Pre. Close: 12.26 Low: 12.66 Market Cap: 518(M)

Short term
Mid term
Targets	6-month :	15.82	1-year :	17.11
Resists	First :	13.54	Second :	14.64
Pivot price	13.3
Supports	First :	11.76	Second :	9.78
MAs	MA(5) :	13.02	MA(20) :	13.41
	MA(100) :	10.96	MA(250) :	8.23
MACD	MACD :	0.1	Signal :	0.2
%K %D	K(14,3) :	24.6	D(3) :	31.1
RSI	RSI(14): 51.5
52-week	High :	14.64	Low :	3.92

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BWAY ] has closed above bottom band by 40.6%. Bollinger Bands are 12.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	12.81 - 12.88	12.88 - 12.94
Low:	11.86 - 11.96	11.96 - 12.03
Close:	12.13 - 12.28	12.28 - 12.39

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Mon, 06 Apr 2026
BrainsWay Ltd (BWAY) Stock Price Down 7.22% on Apr 6 - GuruFocus

Mon, 06 Apr 2026
Why Brainsway (BWAY) might be well poised for a surge - MSN

Mon, 06 Apr 2026
Brainsway (NASDAQ:BWAY) Trading Down 4.4% - What's Next? - MarketBeat

Mon, 06 Apr 2026
Y.D. More Investments Ltd Raises Stock Holdings in Brainsway Ltd. Sponsored ADR $BWAY - MarketBeat

Mon, 06 Apr 2026
MEITAV Investment House holds 5.24% of Brainsway (NASDAQ: BWAY) - Stock Titan

Wed, 01 Apr 2026
Why Brainsway (BWAY) Could Be Positioned for Significant Growth - Bitget

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	40 (M)
Shares Float	23 (M)
Held by Insiders	6 (%)
Held by Institutions	35.1 (%)
Shares Short	116 (K)
Shares Short P.Month	102 (K)

EPS	0.18
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	2
Profit Margin	14.6 %
Operating Margin	13.1 %
Return on Assets (ttm)	2.6 %
Return on Equity (ttm)	11.2 %
Qtrly Rev. Growth	27.3 %
Gross Profit (p.s.)	0.98
Sales Per Share	1.3
EBITDA (p.s.)	0.14
Qtrly Earnings Growth	390.7 %
Operating Cash Flow	18 (M)
Levered Free Cash Flow	1 (M)

PE Ratio	72.94
PEG Ratio	0
Price to Book value	6.56
Price to Sales	10.06
Price to Cash Flow	29.16

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.